Shares of Intellia Therapeutics, Inc. NTLA surged 50.2% after the company reported positive clinical data for its CRISPR therapy.Anavex Life Sciences Corp.’s AVXL shares jumped 16.6% after the company reported that its ANAVEX2-73 has improved MDS-UPDRS efficacy endpoints with significant biomarker correlation in placebo-controlled Phase 2 clinical trial for treatment of Parkinson's.Shares of MannKind Corporation MNKD rose 11.6% after the company reported that Medicare patients will be able to use its Afrezza and continuous glucose monitoring devices starting in July.Kymera Therapeutics, Inc.’s KYMR shares jumped 6.3% after the company reported that its KT-474 has achieved and exceeded Phase 1 target degradation of 85% within the SAD portion of the Phase 1 trial.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MannKind Corporation (MNKD): Free Stock Analysis Report Anavex Life Sciences Corp. (AVXL): Free Stock Analysis Report Intellia Therapeutics, Inc. (NTLA): Free Stock Analysis Report Kymera Therapeutics, Inc. (KYMR): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research